| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 15th September 2020 | Advisors Llc Orbimed | 292,607 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Advisors Llc Orbimed | 902,885 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 292,607 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Advisors Llc Orbimed | 4,822,960 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 902,885 | Grant/award etc. | $0.00 | |
| 15th September 2020 | Carl L Gordon | 4,822,960 | Grant/award etc. | $0.00 | |
| 18th August 2020 | Advisors Llc Orbimed | 43,543 | Open or private sale | $108.54 | $4,726,157.22 |
| 17th August 2020 | Advisors Llc Orbimed | 94,900 | Open or private sale | $107.49 | $10,200,801.00 |
| 14th August 2020 | Advisors Llc Orbimed | 20,257 | Open or private sale | $109.03 | $2,208,620.71 |
| 13th August 2020 | Advisors Llc Orbimed | 29,251 | Open or private sale | $109.93 | $3,215,562.43 |
Turning Point Therapeutics
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
Ticker: TPTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1595893
Employees: 95
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
News
Tesla sues to block Trump tariffs on trade with China
23rd September 2020
Why a president Joe Biden might be great for Tesla stock: analyst
23rd September 2020
Honest Company Founder Jessica Alba: Ethics shouldn’t be a ‘marketing ploy’
23rd September 2020